Oral Session

Oral Session 3-9A Malignant Lymphoma: Case Reports

Sun. Oct 13, 2019 9:00 AM - 10:00 AM No.9 (Tokyo International Forum, 4F G402)

Chair: Motoko Yamaguchi (Department of Hematology and Oncology, Mie University, Tsu, Japan)

+Add all to schedule

[OS3-9A-1] Analysis of RHOA G17V mutation and clinical course of 6 cases with peripheral T-cell lymphoma (PTCL)

Yoshitomo Maesako¹, Hiroko Uesugi¹, Rie Tabata¹, Yusuke Takei² (1.Departmemt of Hematology & Rhematology, Osaka Saiseikai Noe Hospital, Osaka, Japan, 2.Departmemt of Diagnostic Pathology, Osaka Saiseikai Noe Hospital, Osaka, Japan)

[OS3-9A-2] Resolution of EBV-HLH associated with rapid immune reconstitution after a single course CHOP therapy

Yui Chikagawa^1,2, Hiroki Mizumaki¹, Masahiro Fujinaga², Noriharu Nakagawa², Chizuru Saito², Chiharu Sugimori², Takeharu Kotani², Masaki Yamaguchi², Shinji Nakao¹, Akihiro Yachie³ (1.Hematol., Kanazawa Univ., Ishikawa, Japan, 2.Hematol., Ishikawa Prefectural Central Hospital, Ishikawa, Japan, 3.Pediatrics, Kanazawa Univ., Ishikawa, Japan)

[OS3-9A-3] A pediatric case of lymphomatoid granulomatosis associated with a novel primary immunodeficiency

Tomoda Takahiro¹, Motoi Yamashita¹, Takeshi Isoda¹, Kento Inoue¹, Takahiro Kamiya¹, Masakatsu Yanagimachi¹, Kousuke Imai¹, Masatoshi Takagi¹, Morihito Kurata², Hiroaki Miyoshi³, Koichi Ohshima³, Kenichi Imadome⁴, Hirokazu Kanegane¹, Tomohiro Morio¹ (1.Pediatrics., TMDU., Tokyo, Japan, 2.Pathology., TMDU., Tokyo, Japan, 3.Pathology., Kurume University., Fukuoka, Japan, 4.Division of Advanced Medicine for Virus Infections., NCCHD., Tokyo, Japan)

[OS3-9A-4] Arteritis after the administration of granulocyte colony-stimulating factor: a case series

Ken Sasaki¹, Masashi Miyauchi¹, Mizuki Ogura¹, Arika Shimura¹, Kazuhiro Toyama¹, Kumi Nakazaki¹, Takeyuki Watadani², Osamu Abe², Mineo Kurokawa^1,3 (1.Hematology and Oncology, Tokyo University., Tokyo, Japan, 2.Radiology, Tokyo University, Tokyo, Japan, 3.Cell Therapy and Transplantation Medicine, Tokyo University, Tokyo, Japan)

[OS3-9A-5] Successful treatment of systemic Erdheim-Chester disease with interferon-alpha

Mao Wakamatsu¹, Takuya Miyazaki¹, Ayako Matsumura¹, Haruka Teshigawara¹, Hiroshi Teranaka¹, Satoshi Koyama¹, Hiroyuki Takahashi¹, Hiroyoshi Kunimoto¹, Makiko Enaka², Daisuke Kamimura³, Maki Hagihara¹, Kenji Matsumoto¹, Etsuko Yamazaki⁴, Hideaki Nakajima¹ (1.Dept. of Hematol. and Clin. Immuno., Yokohama City Univ., Yokohama, Japan, 2.Dept. of Pathol., Yokohama City Univ. Hosp., Yokohama, Japan, 3.Dept. of Cardiorenal Med., Yokohama City Univ., Yokohama, Japan, 4.Clin. Labo. Dept., Yokohama City Univ. Hosp., Yokohama, Japan)

[OS3-9A-6] Low dose clofarabine based regimen as long term maintenance therapy for lymphoid malignancies

Hideaki Maeba, Kazuhiro Noguchi, Masaki Fukuda, Rie Kuroda, Toshihiro Fujiki, Shintaro Mase, Raita Araki, Yasuhiro Ikawa (Pediatrics, Kanazawa Univ., Kanazawa, Japan)